Geri
MoonLake Immunotherapeutics (MLTX) Fiyatı
MLTX Hisse Senedi Fiyat Grafiği
MLTX Kazanmak
MoonLake Immunotherapeutics
$16.76
2.5%
$0.41
Kapanışta: Jan 16, 16:00:00 GMT-5
$16.16
-3.57%
$-0.6
Ön Piyasa: Jan 20, 06:15:40 GMT-5
Önemli İstatistikler
Önceki Kapanış
$16.35
Açılış fiyatı
$16.39
Günün Aralığı
$16.16 - $16.88
52 haftalık aralık
$5.95 - $62.75
İşlem hacmi
1.4M
Ort.Hacim
4.5M
EPS (TTM)
-3.33
Dividend yield
--
Piyasa Değeri
$1.1B
MLTX nedir?
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. The company is headquartered in Zug, Zug and currently employs 100 full-time employees. The company went IPO on 2020-10-20. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The firm develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved